INFX SYST : Quarterly Report 12/31/2021

Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines

Infrax Systems Inc.
2245 Texas Drive, Suite 300
Sugar Land, TX 77479
_______________________________
281-566-2500
https://infraxinc.com/
[e-mail]
SIC: 5960
QuarterlyReport
For the Period Ending: 12/31/2021
(the "Reporting Period")
As of 12/31/2021, the number of shares outstanding of our Common Stock was:	5,530,894,237
As of 09/30/2021, the number of shares outstanding of our Common Stock was:	5,530,894,237
As of 06/30/2021, the number of shares outstanding of our Common Stock was:	5,530,894,237

Indicate by check mark whether the company is a shell company (as defined in Rule 405 of the Securities Act of 1933 and Rule 12b-2 of the Exchange Act of 1934):

Yes: ☒ No: ☐

Indicate by check mark whether the company's shell status has changed since the previous reporting period:

Yes: ☐ No: ☒

Indicate by check mark whether a Change in Control1 of the company has occurred over this reporting period:

Yes: ☐

No: ☒

1. Name and address(es) of the issuer and its predecessors (if any)

1 "Change in Control" shall mean any events resulting in:

(i) Any "person" (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becoming the "beneficial owner" (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company's then outstanding voting securities;

1. The consummation of the sale or disposition by the Company of all or substantially all of the Company's assets;
2. A change in the composition of the Board occurring within a two (2)-year period, as a result of which fewer than a majority of the directors are directors immediately prior to such change; or
3. The consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation.

OTC Markets Group Inc.
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021)	Page 1 of 9

In answering this item, provide the current name of the issuer any names used by predecessor entities, along with the dates of the name changes.

Infrax Systems, Inc. (formerly OptiCon Systems, Inc.) ("the Company " , "Infrax" ) was formed as a Nevada corporation on October 22, 2004. On July 29, 2005, the stockholders of the Company entered into an agreement to exchange 100% of the outstanding common stock of the Company, for common and preferred stock of FutureWorld Energy, Inc. (formerly Isys Medical, Inc.), a publicly traded company, at which time, the Company became a wholly owned subsidiary of FutureWorld Energy, Inc.

FutureWorld Energy, Inc. ( "FutureWorld" ), Infrax's parent company, announced its intention to spin off Infrax (formerly OptiCon Systems, Inc.) by the payment of a stock dividend. In connection with the proposed spinoff, Infrax's board of directors approved a stock dividend of 99,118 shares to FutureWorld, its sole shareholder. On August 31, 2007, FutureWorld paid a stock dividend to its stockholders, consisting of 100% of the outstanding common stock of the Company, at the rate of one share of Infrax's stock for every two shares they own of FutureWorld. As of August 31, 2007, Infrax ceased being a subsidiary of FutureWorld.

The state of incorporation or registration of the issuer and of each of its predecessors (if any) during the past five years; Please also include the issuer's current standing in its state of incorporation (e.g. active, default, inactive):

The issuer is incorporated in the State of Nevada in good standing and "Active".

Describe any trading suspension orders issued by the SEC concerning the issuer or its predecessors since inception:

N/A

List any stock split, stock dividend, recapitalization, merger, acquisition, spin-off, or reorganization either currently anticipated or that occurred within the past 12 months:

The company plans to acquire an operating company in the first half of 2022.

The address(es) of the issuer's principal executive office:

c/o Krisa Management 2245 Texas Drive, Ste 300 Sugar Land, Texas 77479

The address(es) of the issuer's principal place of business:

Check box if principal executive office and principal place of business are the same address: ☒

c/o Krisa Management 2245 Texas Drive, Ste 300 Sugar Land, Texas 77479

Has the issuer or any of its predecessors been in bankruptcy, receivership, or any similar proceeding in the past five years?

Yes: ☐

No: ☒

If this issuer or any of its predecessors have been the subject of such proceedings, please provide additional details in the space below:

N/A

OTC Markets Group Inc.
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021)	Page 2 of 9

1. Security Information

Trading symbol:		IFXY
Exact title and class of securities outstanding:	Common
CUSIP:		45685T202
Par or stated value:	0.001
Total shares authorized:	6,990,000,000	as of date: 12/31/2021
Total shares outstanding:	5,530,894,237	as of date: 12/31/2021
Number of shares in the Public Float2:	2,063,229,521	as of date: 12/31/2021
Total number of shareholders of record:	74	as of date: 12/31/2021
Trading symbol:		N/A
Exact title and class of securities outstanding:	Preferred
CUSIP:		N/A
Par or stated value:	0.001
Total shares authorized:	10,000,000	as of date: 12/31/2021
Total shares outstanding:	2,490,099	as of date: 12/31/2021
Transfer Agent
Name:	Clear Trust, LLC
Phone:	813.235.4490
Email:	[e-mail]
Address:	16540 Pointe Village Dr., Ste 206, Lutz, FL 33558
Is the Transfer Agent registered under the Exchange Act?3 Yes: ☒	No: ☐

1. Issuance History

The goal of this section is to provide disclosure with respect to each event that resulted in any direct changes to the total shares outstanding of any class of the issuer's securities in the past two completed fiscal years and any subsequent interim period.

Disclosure under this item shall include, in chronological order, all offerings and issuances of securities, including debt convertible into equity securities, whether private or public, and all shares, or any other securities or options to acquire such securities, issued for services. Using the tabular format below, please describe these events.

A. Changes to the Number of Outstanding Shares

Check this box to indicate there were no changes to the number of outstanding shares within the past two completed fiscal years and any subsequent periods: ☒

1. "Public Float" shall mean the total number of unrestricted shares not held directly or indirectly by an officer, director, any person who is the beneficial owner of more than 10 percent of the total shares outstanding (a "control person"), or any affiliates thereof, or any immediate family members of officers, directors and control persons.
2. To be included in the Pink Current Information tier, the transfer agent must be registered under the Exchange Act.

OTC Markets Group Inc.
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021)	Page 3 of 9

Shares Outstanding as of Second Most Recent
Fiscal Year End:	Opening Balance		*Right-click the rows below and select "Insert" to add rows as needed.
Date 06/30/2019	Common:	5,530,894,237
	Preferred:	2,490,099
Date of	Transaction		Number of	Class of	Value of	Were the	Individual/ Entity	Reason for share	Restricted or	Exemption
Transaction	type (e.g. new	Shares	Securities	shares	shares	Shares were	issuance (e.g. for	Unrestricted	or
	issuance,		Issued (or		issued	issued at	issued to	cash or debt	as of this	Registration
	cancellation,		cancelled)		($/per	a discount	(entities must	conversion)	filing.	Type.
	shares				share) at	to market	have individual	-OR-
	returned to				Issuance	price at	with voting /	Nature of
	treasury)					the time	investment	Services
						of	control	Provided
						issuance?	disclosed).
						(Yes/No)
Shares Outstanding on Date of This Report:
	Ending Balance
Date 12/31/2021	Common:	5,530,894,237
	Preferred:	2,490,099

*Note: On June 14, 2021, in a private transaction, the custodian entered into a Securities Purchase Agreement with Krisa Management LLC, a Texas limited liability company controlled by Carey Cooley, to sell the Special 2021 Series A Preferred Stock for $20,000 to be paid in cash or any marketable security held by the borrower.

B. Debt Securities, Including Promissory and Convertible Notes

Use the chart and additional space below to list and describe all outstanding promissory notes, convertible notes, convertible debentures, or any other debt instruments that may be converted into a class of the issuer's equity securities.

Check this box if there are no outstanding promissory, convertible notes or debt arrangements: ☒

Date of	Outstanding	Principal	Interest	Maturity	Conversion Terms (e.g.	Name of Noteholder	Reason for
Note	Balance ($)	Amount	Accrued	Date	pricing mechanism for	(entities must have	Issuance (e.g.
Issuance		at	($)		determining conversion of	individual with voting	Loan, Services,
		Issuance			instrument to shares)	/ investment control	etc.)
		($)				disclosed).

Use the space below to provide any additional details, including footnotes to the table above:

N/A

1. Financial Statements

A. The following financial statements were prepared in accordance with:

OTC Markets Group Inc.
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021)	Page 4 of 9

1. ☒ U.S. GAAP ☐ IFRS

2. The financial statements for this reporting period were prepared by (name of individual)4:

Name:	Carey W. Cooley
Title:	President, CEO
Relationship to Issuer:	Sole Officer, Director

Provide the financial statements described below for the most recent fiscal year or quarter. For the initial disclosure statement (qualifying for Pink Current Information for the first time) please provide reports for the two previous fiscal years and any subsequent interim periods.

1. Balance sheet;
2. Statement of income;
3. Statement of cash flows;
4. Statement of Retained Earnings (Statement of Changes in Stockholders' Equity)
5. Financial notes; and
6. Audit letter, if audited

You may either (i) attach/append the financial statements to this disclosure statement or (ii) file the financial statements through OTCIQ as a separate report using the appropriate report name for the applicable period end. ("Annual Report," "Quarterly Report" or "Interim Report").

If you choose to publish the financial statements in a separate report as described above, you must state in the accompanying disclosure statement that such financial statements are incorporated by reference. You may reference the document(s) containing the required financial statements by indicating the document name, period end date, and the date that it was posted to OTCIQ in the field below. Financial Statements must be compiled in one document.

Documents C-G are incorporated herein.

Financial statement information is considered current until the due date for the subsequent report (as set forth in the qualifications section above). To remain qualified for Current Information, a company must post its Annual Report within 90 days from its fiscal year-end date and Quarterly Reports within 45 days of each fiscal quarter-end date.

1. Issuer's Business, Products and Services

The purpose of this section is to provide a clear description of the issuer's current operations. In answering this item, please include the following:

1. Summarize the issuer's business operations (If the issuer does not have current operations, state "no operations")
   No operations.
2. Please list any subsidiaries, parents, or affiliated companies. No operations.
3. Describe the issuers' principal products or services.

4 The financial statements requested pursuant to this item must be prepared in accordance with US GAAP or IFRS by persons with sufficient financial skills.

OTC Markets Group Inc.
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021)	Page 5 of 9